DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seok-Min Kim | - |
dc.contributor.author | Se-Chan Oh | - |
dc.contributor.author | Sun-Young Lee | - |
dc.contributor.author | Ling-Zu Kong | - |
dc.contributor.author | J H Lee | - |
dc.contributor.author | Tae-Don Kim | - |
dc.date.accessioned | 2023-04-10T16:33:53Z | - |
dc.date.available | 2023-04-10T16:33:53Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 1469-221X | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/31579 | - |
dc.description.abstract | N6 -Methyladenosine (m6 A) is the most abundant epitranscriptomic mark and plays a fundamental role in almost every aspect of mRNA metabolism. Although m6 A writers and readers have been widely studied, the roles of m6 A erasers are not well-understood. Here, we investigate the role of FTO, one of the m6 A erasers, in natural killer (NK) cell immunity. We observe that FTO-deficient NK cells are hyperactivated. Fto knockout (Fto-/- ) mouse NK cells prevent melanoma metastasis in vivo, and FTO-deficient human NK cells enhance the antitumor response against leukemia in vitro. We find that FTO negatively regulates IL-2/15-driven JAK/STAT signaling by increasing the mRNA stability of suppressor of cytokine signaling protein (SOCS) family genes. Our results suggest that FTO is an essential modulator of NK cell immunity, providing a new immunotherapeutic strategy for allogeneic NK cell therapies. | - |
dc.publisher | Wiley | - |
dc.title | FTO negatively regulates the cytotoxic activity of natural killer cells | - |
dc.title.alternative | FTO negatively regulates the cytotoxic activity of natural killer cells | - |
dc.type | Article | - |
dc.citation.title | EMBO Reports | - |
dc.citation.number | 4 | - |
dc.citation.endPage | e55681 | - |
dc.citation.startPage | e55681 | - |
dc.citation.volume | 24 | - |
dc.contributor.affiliatedAuthor | Seok-Min Kim | - |
dc.contributor.affiliatedAuthor | Se-Chan Oh | - |
dc.contributor.affiliatedAuthor | Sun-Young Lee | - |
dc.contributor.affiliatedAuthor | Ling-Zu Kong | - |
dc.contributor.affiliatedAuthor | Tae-Don Kim | - |
dc.contributor.alternativeName | 김석민 | - |
dc.contributor.alternativeName | 오세찬 | - |
dc.contributor.alternativeName | 이선영 | - |
dc.contributor.alternativeName | 공링주 | - |
dc.contributor.alternativeName | 이종희 | - |
dc.contributor.alternativeName | 김태돈 | - |
dc.identifier.bibliographicCitation | EMBO Reports, vol. 24, no. 4, pp. e55681-e55681 | - |
dc.identifier.doi | 10.15252/embr.202255681 | - |
dc.subject.keyword | Epitranscriptome | - |
dc.subject.keyword | FTO | - |
dc.subject.keyword | m6A regulator | - |
dc.subject.keyword | N6-methyladenosine | - |
dc.subject.keyword | NK cell | - |
dc.subject.local | FTO | - |
dc.subject.local | N6-methyladenosine | - |
dc.subject.local | NK cell | - |
dc.subject.local | NK cells | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.